Biocon Biologics, a subsidiary of Biocon, has secured EU marketing authorisation for its Denosumab biosimilars Vevzuo and ...

If osteoporosis patients stop taking injectable bisphosphonate used to treat osteoporosis before dental treatment for a ...

With the emergence of iSN40 and similar oligodeoxynucleotides, the future of osteoporosis treatment looks promising. This story is part of a series on the current progression in Regenerative Medicine.

Standard first-line drug therapies for the treatment of bone density disorders have been linked to higher risk of experiencing a cardiovascular event, according to a study published June 26 in Epic ...

Osteoporosis treatment involves both medication (like bisphosphonates) and lifestyle changes (diet, exercise), with a lifelong approach to maintaining bone health being crucial.

Bisphosphonates: These are antiresorptive medications that prevent bone loss by reducing bone resorption (the breakdown of old bone).They are considered first-line treatments for osteoporosis and ...

Osteoporosis treatment reduces the risk for hip fractures for older men just as well as it does for older women, according to a study published in Journal of Bone and Mineral Research. “There is ...

Osteoporosis is a disease that makes bones weak and more likely to break. Sometimes, a person may break a bone from a small ...

Samsung Bioepis announced on the 1st that it will launch the osteoporosis treatment for menopausal women, Obodence ...

Osteoporosis patients face a 'wild west' for prescriptions - with two-thirds struggling to get their medication. By LUKE CHAFER. Published: 19:20 EDT, 5 April 2025 | Updated: 19:24 EDT, 5 April 2025 ...

The global osteoporosis drugs market size was valued at USD 14.90 billion in 2024 and is projected to reach USD 15.39 billion in 2025 to USD 19.96 billion by 2033, growing at a CAGR of 3.3% during ...